thalidomide has been researched along with Lentigines in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vazquez, B | 1 |
| Gonzalez, V | 1 |
| Molina, I | 1 |
| Montesinos, E | 1 |
| Ramon, MD | 1 |
| Monteagudo, C | 1 |
| McCarthy, S | 1 |
| Heffron, CCBB | 1 |
| Murphy, M | 1 |
| Sfecci, A | 1 |
| Khemis, A | 1 |
| Lacour, JP | 1 |
| Montaudié, H | 1 |
| Passeron, T | 1 |
3 other studies available for thalidomide and Lentigines
| Article | Year |
|---|---|
Multiple lentigines arising on resolving psoriatic plaques after treatment with apremilast.
Topics: Humans; Lentigo; Male; Middle Aged; Phosphodiesterase Inhibitors; Psoriasis; Skin; Thalidomide | 2019 |
Lentigines within fixed drug eruption: reply to 'Multiple lentigines arising on resolving psoriatic plaques after treatment with apremilast'.
Topics: Adult; Dermoscopy; Drug Eruptions; Exanthema; Female; Humans; Hyperpigmentation; Inflammation; Lenti | 2019 |
Appearance of lentigines in psoriasis patients treated with apremilast.
Topics: Adult; Aged; Clinical Trials, Phase III as Topic; Female; Humans; Lentigo; Male; Middle Aged; Phosph | 2016 |